These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 16708769)

  • 1. Mercury elimination with oral DMPS, DMSA, vitamin C, and glutathione: an observational clinical review.
    Muran PJ
    Altern Ther Health Med; 2006; 12(3):70-5. PubMed ID: 16708769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin C, glutathione, or lipoic acid did not decrease brain or kidney mercury in rats exposed to mercury vapor.
    Aposhian HV; Morgan DL; Queen HL; Maiorino RM; Aposhian MM
    J Toxicol Clin Toxicol; 2003; 41(4):339-47. PubMed ID: 12870874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of 2,3-dimercaptopropane-1-sulfonate (DMPS) and meso-2,3-dimercaptosuccinic acid (DMSA) on the renal disposition of mercury in normal and uninephrectomized rats exposed to inorganic mercury.
    Zalups RK
    J Pharmacol Exp Ther; 1993 Nov; 267(2):791-800. PubMed ID: 8246154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neither DMPS nor DMSA is effective in quantitative elimination of elemental mercury after intentional IV injection.
    Eyer F; Felgenhauer N; Pfab R; Drasch G; Zilker T
    Clin Toxicol (Phila); 2006; 44(4):395-7. PubMed ID: 16809143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mercury binding to the chelation therapy agents DMSA and DMPS and the rational design of custom chelators for mercury.
    George GN; Prince RC; Gailer J; Buttigieg GA; Denton MB; Harris HH; Pickering IJ
    Chem Res Toxicol; 2004 Aug; 17(8):999-1006. PubMed ID: 15310232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. meso-2,3-dimercaptosuccinic acid monoalkyl esters: effects on mercury levels in mice.
    Gale GR; Smith AB; Jones MM; Singh PK
    Toxicology; 1993 Jul; 81(1):49-56. PubMed ID: 8396277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chelation therapy in intoxications with mercury, lead and copper.
    Cao Y; Skaug MA; Andersen O; Aaseth J
    J Trace Elem Med Biol; 2015; 31():188-92. PubMed ID: 24894443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous administration of sodium selenite and mercuric chloride decreases efficacy of DMSA and DMPS in mercury elimination in rats.
    Juresa D; Blanusa M; Kostial K
    Toxicol Lett; 2005 Jan; 155(1):97-102. PubMed ID: 15585364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships between the renal handling of DMPS and DMSA and the renal handling of mercury.
    Zalups RK; Bridges CC
    Chem Res Toxicol; 2012 Sep; 25(9):1825-38. PubMed ID: 22667351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mercury toxicity and antioxidants: Part 1: role of glutathione and alpha-lipoic acid in the treatment of mercury toxicity.
    Patrick L
    Altern Med Rev; 2002 Dec; 7(6):456-71. PubMed ID: 12495372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mobilization of mercury by DMPS in occupationally exposed workers and in model experiments on rats: evaluation of body burden.
    Nerudová J; Cábelková Z; Frantík E; Lukás E; Urban P; Bláha K; Pelclová D; Lebedová J; Cikrt M
    Int J Occup Med Environ Health; 2000; 13(2):131-46. PubMed ID: 10967843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human studies with the chelating agents, DMPS and DMSA.
    Aposhian HV; Maiorino RM; Rivera M; Bruce DC; Dart RC; Hurlbut KM; Levine DJ; Zheng W; Fernando Q; Carter D
    J Toxicol Clin Toxicol; 1992; 30(4):505-28. PubMed ID: 1331491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stevens-Johnson syndrome in a child with chronic mercury exposure and 2,3-dimercaptopropane-1-sulfonate (DMPS) therapy.
    Van der Linde AA; Pillen S; Gerrits GP; Bouwes Bavinck JN
    Clin Toxicol (Phila); 2008 Jun; 46(5):479-81. PubMed ID: 18568806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of DMPS and DMSA on the placental and fetal disposition of methylmercury.
    Bridges CC; Joshee L; Zalups RK
    Placenta; 2009 Sep; 30(9):800-5. PubMed ID: 19615742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidrug resistance proteins and the renal elimination of inorganic mercury mediated by 2,3-dimercaptopropane-1-sulfonic acid and meso-2,3-dimercaptosuccinic acid.
    Bridges CC; Joshee L; Zalups RK
    J Pharmacol Exp Ther; 2008 Jan; 324(1):383-90. PubMed ID: 17940195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inorganic mercury poisoning associated with skin-lightening cosmetic products.
    Chan TY
    Clin Toxicol (Phila); 2011 Dec; 49(10):886-91. PubMed ID: 22070559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicokinetics and toxicodynamics of elemental mercury following self-administration.
    De Palma G; Mariotti O; Lonati D; Goldoni M; Catalani S; Mutti A; Locatelli C; Apostoli P
    Clin Toxicol (Phila); 2008 Nov; 46(9):869-76. PubMed ID: 18787993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary mercury in twelve cases of cutaneous mercurous chloride (calomel) exposure: effect of sodium 2,3-dimercaptopropane-1-sulfonate (DMPS) therapy.
    Garza-Ocañas L; Torres-Alanís O; Piñeyro-López A
    J Toxicol Clin Toxicol; 1997; 35(6):653-5. PubMed ID: 9365436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The therapeutic use of 2,3-dimercaptopropane-1-sulfonate in two cases of inorganic mercury poisoning.
    Campbell JR; Clarkson TW; Omar MD
    JAMA; 1986 Dec; 256(22):3127-30. PubMed ID: 3783847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term follow-up after intravenous injection of mercury--two cases report].
    Goszcz H; Szczepańska Ł; Lech T; Groszek B
    Przegl Lek; 2012; 69(8):580-4. PubMed ID: 23243934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.